Cardiac microcurrent therapy improves LVEF, exercise capacity in patients with HF
PHOENIX — Cardiac microcurrent therapy, implanted surgically or subcutaneously, improved left ventricular ejection fraction and showed signals of improved exercise capacity in patients with heart failure, speakers reported.Positive results of the C-MIC II and C-MIC III trials of two cardiac microcurrent therapy devices (C-MIC, Berlin Heals Holding AG) designed to improve cardiac function Cardiac microcurrent therapy, implanted surgically or subcutaneously, improved left ventricular ejection fraction (LVEF) and exercise capacity in patients with heart failure. The results were presented at the Heart Failure Society of America Annual Scientific Meeting in Phoenix. The devices can either be surgically (subcutaneously) or surgically implanted. Dragana Kosevic, MD, cardiologist at Cardiovascular Institute Dedinje in Belgrade, Serbia, found a 5.1% improvement in LVEF among patients assigned to cardiac microcurrent Therapy vs. guideline-directed medical therapy. Key secondary efficacy endpoints included NYHA class improvement of one or more, Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score improvement of 5 points or more; and improvement in 6-minute walk distance of at least 30%. Body weight remained stable and did not significantly change in both groups.
Pubblicato : 6 ore fa di Scott Buzby in Health Science
Cardiac microcurrent therapy improved LVEF and exercise capacity for patients with heart failure.
• The devices can either be surgically or subcutaneously implanted.
PHOENIX — Cardiac microcurrent th... [6152 symbols]
